Cargando…
WRAP53β, survivin and p16(INK4a) expression as potential predictors of radiotherapy/chemoradiotherapy response in T2N0-T3N0 glottic laryngeal cancer
The current treatment recommendation for T2-3N0M0 glottic squamous cell carcinoma (SCC) in the Nordic countries comprises of radiotherapy (RT) and chemoradiotherapy (CRT). Tumor radiosensitivity varies and another option is primary surgical treatment, which underlines the need for predictive markers...
Autores principales: | Tiefenböck-Hansson, Katharina, Haapaniemi, Aaro, Farnebo, Lovisa, Palmgren, Björn, Tarkkanen, Jussi, Farnebo, Marianne, Munck-Wikland, Eva, Mäkitie, Antti, Garvin, Stina, Roberg, Karin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652956/ https://www.ncbi.nlm.nih.gov/pubmed/28849066 http://dx.doi.org/10.3892/or.2017.5898 |
Ejemplares similares
-
WRAP53 promotes cancer cell survival and is a potential target for cancer therapy
por: Mahmoudi, S, et al.
Publicado: (2011) -
On the road with WRAP53β: guardian of Cajal bodies and genome integrity
por: Henriksson, Sofia, et al.
Publicado: (2015) -
Downregulation of the cancer susceptibility protein WRAP53β in epithelial ovarian cancer leads to defective DNA repair and poor clinical outcome
por: Hedström, E, et al.
Publicado: (2015) -
A Nordic survey of the management of palliative care in patients with head and neck cancer
por: Boëthius, Helena, et al.
Publicado: (2020) -
Early mortality after diagnosis of cancer of the head and neck – A population-based nationwide study
por: Talani, Charbél, et al.
Publicado: (2019)